Genetic approaches to cancer therapy

COX2 Effects on endometrial carcinomas progression.

Pathology, research and practice·2022

How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020

Heavy metals effect on breast cancer progression.

Journal of occupational medicine and toxicology (London, England)·2017

RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2011

Overcoming challenges of cancer treatment programmes in developing countries: a sustainable breast cancer initiative in Ethiopia.

Clinical oncology (Royal College of Radiologists (Great Britain))·2008

Thymic expression of mutated B16:A preproinsulin messenger RNA does not reverse acceleration of NOD diabetes associated with insulin 2 (thymic expressed insulin) knockout.

Journal of autoimmunity·2005

Bone- and muscle-targeted adeno-associated viral vectors enable tissue-selective vitamin D receptor knockdown in mice.

Gene therapy·2026

rAAV production cost analysis: Indication-specific cost per dose and reduction strategies.

Gene therapy·2026

Gene augmentation therapy successfully treats mice with complete congenital stationary night blindness (cCSNB), improving retinal function and visual acuity.

Gene therapy·2026

Reversing cancer cell behavior using AI-guided CRISPR and quantum nanobiology: a systems-based approach to epigenetic reprogramming.

Gene therapy·2026

FMR1 gene therapy restores translationally relevant phenotypes in a mouse model for fragile X syndrome.

Gene therapy·2026

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026

FUNDC1-mediated mitochondrial quality control protects against immune checkpoint inhibitor-associated cardiac injury.

Immunologic research·2026

Ferroptosis suppression by MYC confers oxaliplatin resistance in colorectal cancer via FTH1 and GPX4.

Cancer chemotherapy and pharmacology·2026

EID1 blockade potentiates immunosurveillance against cancer metastasis via FPR1-mediated DC-NK crosstalk.

Science China. Life sciences·2026

Distinct Gut Microbiome and Metabolome Profiles Associate with Differential Responses to Immunotherapy in Colorectal Cancer.

Polish journal of microbiology·2026

AI-Driven Multiomics Biomarkers for Precision Oncology: Navigating the Translational Gap and Regulatory Hurdles.

Omics : a journal of integrative biology·2026

Long non-coding RNA LOC101926915-encoded micropeptide carboplatin-induced upregulation factor confers carboplatin resistance in ovarian cancer.

CytoJournal·2026

Related Experiment Videos

Genetic approaches to cancer therapy

Related Concept Videos

COX2 Effects on endometrial carcinomas progression.

How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.

Heavy metals effect on breast cancer progression.

RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.

Overcoming challenges of cancer treatment programmes in developing countries: a sustainable breast cancer initiative in Ethiopia.

Thymic expression of mutated B16:A preproinsulin messenger RNA does not reverse acceleration of NOD diabetes associated with insulin 2 (thymic expressed insulin) knockout.

Bone- and muscle-targeted adeno-associated viral vectors enable tissue-selective vitamin D receptor knockdown in mice.

rAAV production cost analysis: Indication-specific cost per dose and reduction strategies.

Gene augmentation therapy successfully treats mice with complete congenital stationary night blindness (cCSNB), improving retinal function and visual acuity.

Reversing cancer cell behavior using AI-guided CRISPR and quantum nanobiology: a systems-based approach to epigenetic reprogramming.

FMR1 gene therapy restores translationally relevant phenotypes in a mouse model for fragile X syndrome.

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

FUNDC1-mediated mitochondrial quality control protects against immune checkpoint inhibitor-associated cardiac injury.

Ferroptosis suppression by MYC confers oxaliplatin resistance in colorectal cancer via FTH1 and GPX4.

EID1 blockade potentiates immunosurveillance against cancer metastasis via FPR1-mediated DC-NK crosstalk.

Distinct Gut Microbiome and Metabolome Profiles Associate with Differential Responses to Immunotherapy in Colorectal Cancer.

AI-Driven Multiomics Biomarkers for Precision Oncology: Navigating the Translational Gap and Regulatory Hurdles.

Long non-coding RNA LOC101926915-encoded micropeptide carboplatin-induced upregulation factor confers carboplatin resistance in ovarian cancer.

Related Experiment Videos

Genetic approaches to cancer therapy

Related Concept Videos

Related Articles